FDA Tries Again To Ban Kratom
As someone interested in medical strategies for disaster or remote settings, I was considering the herb as an option in circumstances when modern medicine isn’t available. The FDA, however, set a date for late 2016 to rule Kratom a Schedule I drug (the same category as heroin) and eliminate its access to the average citizen.
Then an extraordinary thing happened: A public outcry from tens of thousands of citizens that also included dozens of members of Congress. In response to the pressure, the proposed ban was cancelled. Now, a persistent FDA is once again pushing to prevent the sale and use of Kratom in the U.S.
Kratom (scientific name Mitragyna speciosa)This post was originally published on this site